MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
469.00
3 (0.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Strong Long Term Fundamental Strength with a 30.65% CAGR growth in Operating Profits

  • Company has a low Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 14.67% signifying high profitability per unit of shareholders funds
2

Positive results in Dec 25

3

With ROE of 15.26%, it has a very expensive valuation with a 6.21 Price to Book Value

4

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 7,154 Million (Small Cap)

stock-summary
P/E

41.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.08

stock-summary
Return on Equity

15.61%

stock-summary
Price to Book

4.93

Revenue and Profits:
Net Sales:
591 Million
(Quarterly Results - Dec 2025)
Net Profit:
65 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.57%
0%
-14.57%
6 Months
-17.43%
0%
-17.43%
1 Year
37.94%
0%
37.94%
2 Years
21.03%
0%
21.03%
3 Years
85.01%
0%
85.01%
4 Years
179.83%
0%
179.83%
5 Years
133.92%
0%
133.92%

MedCap AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
20.86%
EBIT Growth (5y)
30.65%
EBIT to Interest (avg)
10.65
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
1.31
Tax Ratio
20.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.53%
ROE (avg)
14.67%

Valuation key factors

Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
6.21
EV to EBIT
32.36
EV to EBITDA
21.60
EV to Capital Employed
7.31
EV to Sales
4.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
22.60%
ROE (Latest)
15.26%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 24.63% vs 3.85% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 52.46% vs -31.68% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "591.00",
          "val2": "474.20",
          "chgp": "24.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "131.10",
          "val2": "79.90",
          "chgp": "64.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.30",
          "val2": "4.80",
          "chgp": "197.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.80",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "65.10",
          "val2": "42.70",
          "chgp": "52.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "134.90%",
          "val2": "105.40%",
          "chgp": "2.95%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 16.68% vs 13.82% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 5.50% vs 21.28% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,108.00",
          "val2": "1,806.70",
          "chgp": "16.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "432.70",
          "val2": "345.90",
          "chgp": "25.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "31.50",
          "val2": "18.50",
          "chgp": "70.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.50",
          "val2": "21.10",
          "chgp": "-97.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "220.70",
          "val2": "209.20",
          "chgp": "5.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "142.40%",
          "val2": "135.30%",
          "chgp": "0.71%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
591.00
474.20
24.63%
Operating Profit (PBDIT) excl Other Income
131.10
79.90
64.08%
Interest
14.30
4.80
197.92%
Exceptional Items
0.00
-0.80
100.00%
Consolidate Net Profit
65.10
42.70
52.46%
Operating Profit Margin (Excl OI)
134.90%
105.40%
2.95%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 24.63% vs 3.85% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 52.46% vs -31.68% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
2,108.00
1,806.70
16.68%
Operating Profit (PBDIT) excl Other Income
432.70
345.90
25.09%
Interest
31.50
18.50
70.27%
Exceptional Items
0.50
21.10
-97.63%
Consolidate Net Profit
220.70
209.20
5.50%
Operating Profit Margin (Excl OI)
142.40%
135.30%
0.71%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 16.68% vs 13.82% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 5.50% vs 21.28% in Dec 2024

stock-summaryCompany CV
About MedCap AB stock-summary
stock-summary
MedCap AB
Pharmaceuticals & Biotechnology
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Company Coordinates stock-summary
Company Details
Sundbybergsvagen 1 , SOLNA None : 171 73
stock-summary
Tel: 46 8 34711046 8 347110
stock-summary
Registrar Details